Pepdox
Studies
Peptides
Calculator
Patient-Reported Outcomes in People With Type 2 Diabetes Escalating Dulaglutide or Switching From Dulaglutide to Tirzepatide. | Pepdox
Home
/
Search
/
PMID 41911554
Patient-Reported Outcomes in People With Type 2 Diabetes Escalating Dulaglutide or Switching From Dulaglutide to Tirzepatide.
Annals of internal medicine
2026
PMID: 41911554
View on PubMed
DOI: 10.7326/ANNALS-25-03219
Tirzepatide
Authors
Boye, Kristina S; Sharma, Palash; Chivukula, Karthik K; Farrell, Emer B; Kwan, Anita Y M